IL75403A - Sustained release pharmaceutical compositions containing a pyridinone derivative for oral administration - Google Patents
Sustained release pharmaceutical compositions containing a pyridinone derivative for oral administrationInfo
- Publication number
- IL75403A IL75403A IL75403A IL7540385A IL75403A IL 75403 A IL75403 A IL 75403A IL 75403 A IL75403 A IL 75403A IL 7540385 A IL7540385 A IL 7540385A IL 75403 A IL75403 A IL 75403A
- Authority
- IL
- Israel
- Prior art keywords
- sustained release
- oral administration
- pharmaceutical compositions
- compositions containing
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848414220A GB8414220D0 (en) | 1984-06-04 | 1984-06-04 | Medicaments in unit dose form |
Publications (1)
Publication Number | Publication Date |
---|---|
IL75403A true IL75403A (en) | 1988-08-31 |
Family
ID=10561912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL75403A IL75403A (en) | 1984-06-04 | 1985-06-04 | Sustained release pharmaceutical compositions containing a pyridinone derivative for oral administration |
Country Status (20)
Country | Link |
---|---|
US (1) | US4806361A (xx) |
EP (1) | EP0164959B1 (xx) |
JP (1) | JPS611614A (xx) |
KR (1) | KR920004094B1 (xx) |
AT (1) | ATE73323T1 (xx) |
AU (1) | AU573006B2 (xx) |
CA (1) | CA1258232A (xx) |
DE (1) | DE3585560D1 (xx) |
DK (1) | DK164259C (xx) |
ES (1) | ES8608863A1 (xx) |
FI (1) | FI87990C (xx) |
GB (1) | GB8414220D0 (xx) |
GR (1) | GR851356B (xx) |
IL (1) | IL75403A (xx) |
MX (1) | MX159928A (xx) |
NO (1) | NO166063C (xx) |
NZ (1) | NZ212268A (xx) |
PH (1) | PH24225A (xx) |
PT (1) | PT80583B (xx) |
ZA (1) | ZA854116B (xx) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5862314A (ja) * | 1981-10-07 | 1983-04-13 | Mazda Motor Corp | 過給機付エンジンの吸気装置 |
JPS5993939A (ja) * | 1982-11-19 | 1984-05-30 | Toyota Motor Corp | 内燃機関のノツキング制御装置 |
JPS6327424A (ja) * | 1986-07-17 | 1988-02-05 | Shionogi & Co Ltd | 徐放性製剤およびその製造法 |
JPH07100665B2 (ja) * | 1987-12-23 | 1995-11-01 | 信越化学工業株式会社 | 被覆薬剤の製造方法 |
JPH01165520A (ja) * | 1987-12-23 | 1989-06-29 | Shin Etsu Chem Co Ltd | 持続性製剤およびその製造方法 |
US4880636A (en) * | 1988-05-13 | 1989-11-14 | Franz Robert M | Film coated tablet of ranitidine HCl |
US4938968A (en) * | 1988-07-26 | 1990-07-03 | Norjec Development Associates, Inc. | Controlled release indomethacin |
US5196203A (en) * | 1989-01-06 | 1993-03-23 | F. H. Faulding & Co. Limited | Theophylline dosage form |
US5330766A (en) * | 1989-01-06 | 1994-07-19 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
CA2007055A1 (en) * | 1989-01-06 | 1990-07-06 | Garth Boehm | Theophylline dosage form |
US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
CA2007181C (en) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
US5213811A (en) * | 1991-09-13 | 1993-05-25 | Sterling Drug Inc. | Oral sustained-release drug compositions |
JPH05149118A (ja) * | 1991-11-29 | 1993-06-15 | Mitsubishi Motors Corp | エンジンの圧縮比を変化させる方法 |
US5328697A (en) * | 1992-02-10 | 1994-07-12 | Mallinckrodt Veterinary, Inc. | Compositions and processes for the sustained release of drugs |
US7008668B2 (en) | 1995-05-09 | 2006-03-07 | Phoqus Pharmaceuticals Limited | Powder coating composition for electrostatic coating of pharmaceutical substrates |
ES2194100T3 (es) | 1995-05-09 | 2003-11-16 | Phoqus Ltd | Revestimiento electrostatico. |
GB9623634D0 (en) | 1996-11-13 | 1997-01-08 | Bpsi Holdings Inc | Method and apparatus for the coating of substrates for pharmaceutical use |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
FR2758461A1 (fr) * | 1997-01-17 | 1998-07-24 | Pharma Pass | Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation |
UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
FR2795961B1 (fr) | 1999-07-09 | 2004-05-28 | Ethypharm Lab Prod Ethiques | Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation |
US7863331B2 (en) | 1999-07-09 | 2011-01-04 | Ethypharm | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
FR2796840B1 (fr) * | 1999-07-26 | 2003-06-20 | Ethypharm Lab Prod Ethiques | Comprimes faiblement doses et procede de preparation |
US6475493B1 (en) | 1999-09-02 | 2002-11-05 | Norstrum Pharmaceuticals, Inc. | Controlled release pellet formulation |
GB0002305D0 (en) | 2000-02-01 | 2000-03-22 | Phoqus Limited | Power material for electrostatic application |
JP2002003366A (ja) * | 2000-06-23 | 2002-01-09 | Freunt Ind Co Ltd | 固形薬剤用水系コーティング剤組成物 |
GB0407312D0 (en) | 2004-03-31 | 2004-05-05 | Phoqus Pharmaceuticals Ltd | Method and apparatus for the application of powder material to substrates |
EP2161036B1 (en) * | 2007-06-06 | 2014-12-10 | Asahi Kasei Chemicals Corporation | Cellulose fine core particle, and method for production thereof |
CA2845228C (en) | 2011-08-16 | 2021-08-10 | Baker Idi Heart & Diabetes Institute Holdings Limited | Oral controlled-release formulation of 5-(pyridinyl)-2(1h)-pyridinone compounds |
BR112017013015A2 (pt) | 2014-12-22 | 2018-03-06 | Cardiora Pty Ltd | método de tratamento de um paciente que possui falência cardíaca com fração de ejeção preservada (hfpef) |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2921883A (en) * | 1957-05-03 | 1960-01-19 | Smith Kline French Lab | Novel coating material for medicaments |
US2887440A (en) * | 1957-08-12 | 1959-05-19 | Dow Chemical Co | Enteric coating |
US3328256A (en) * | 1963-05-27 | 1967-06-27 | William E Gaunt | Spherical beads and their production |
US3492397A (en) * | 1967-04-07 | 1970-01-27 | Warner Lambert Pharmaceutical | Sustained release dosage in the pellet form and process thereof |
JPS50129727A (xx) * | 1974-04-04 | 1975-10-14 | ||
FR2313915A1 (fr) * | 1976-01-26 | 1977-01-07 | Corneille Gilbert | Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme |
GB1561204A (en) * | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
US4180559A (en) * | 1978-01-05 | 1979-12-25 | Richardson-Merrell Inc. | Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
JPS5535031A (en) * | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
SE7813246L (sv) * | 1978-12-22 | 1980-06-23 | Haessle Ab | Fast farmaceutisk beredning innehallande kroppar med flera ytskikt |
US4248858A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4313951A (en) * | 1979-11-26 | 1982-02-02 | Sterling Drug Inc. | 3-Substituted-6-(lower-alkyl)-5-(pyridinyl)-2(1H)-pyridinones, their cardiotonic use and intermediates therefor |
NZ195564A (en) * | 1979-11-26 | 1983-09-30 | Sterling Drug Inc | 5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds |
DE3000979A1 (de) * | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
DE3126703A1 (de) * | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
JPS58116414A (ja) * | 1981-12-23 | 1983-07-11 | Yamanouchi Pharmaceut Co Ltd | ニカルジピン持続性製剤用球形顆粒およびその製造法 |
MX7567E (es) * | 1981-12-23 | 1989-10-27 | Yamanouchi Pharma Co Ltd | Procedimiento para recubrir nicardipina de accion prolongada |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
DE3237575A1 (de) * | 1982-10-09 | 1984-04-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale mopidamolformen |
FR2556964A1 (fr) * | 1983-12-23 | 1985-06-28 | Ile De France | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
-
1984
- 1984-06-04 GB GB848414220A patent/GB8414220D0/en active Pending
-
1985
- 1985-05-24 US US06/738,133 patent/US4806361A/en not_active Expired - Fee Related
- 1985-05-30 ZA ZA854116A patent/ZA854116B/xx unknown
- 1985-05-30 EP EP85303793A patent/EP0164959B1/en not_active Expired - Lifetime
- 1985-05-30 AT AT85303793T patent/ATE73323T1/de not_active IP Right Cessation
- 1985-05-30 DE DE8585303793T patent/DE3585560D1/de not_active Expired - Fee Related
- 1985-05-31 PH PH32344A patent/PH24225A/en unknown
- 1985-05-31 NZ NZ212268A patent/NZ212268A/xx unknown
- 1985-06-03 KR KR1019850003861A patent/KR920004094B1/ko active IP Right Grant
- 1985-06-03 ES ES543826A patent/ES8608863A1/es not_active Expired
- 1985-06-03 NO NO852225A patent/NO166063C/no unknown
- 1985-06-03 DK DK247285A patent/DK164259C/da not_active IP Right Cessation
- 1985-06-03 AU AU43236/85A patent/AU573006B2/en not_active Ceased
- 1985-06-03 CA CA000483000A patent/CA1258232A/en not_active Expired
- 1985-06-04 FI FI852235A patent/FI87990C/fi not_active IP Right Cessation
- 1985-06-04 GR GR851356A patent/GR851356B/el unknown
- 1985-06-04 PT PT80583A patent/PT80583B/pt not_active IP Right Cessation
- 1985-06-04 MX MX8264A patent/MX159928A/es unknown
- 1985-06-04 JP JP60121368A patent/JPS611614A/ja active Pending
- 1985-06-04 IL IL75403A patent/IL75403A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB8414220D0 (en) | 1984-07-11 |
AU573006B2 (en) | 1988-05-26 |
EP0164959A3 (en) | 1986-12-17 |
ZA854116B (en) | 1986-01-29 |
NO166063C (no) | 1991-05-29 |
PH24225A (en) | 1990-04-10 |
KR920004094B1 (ko) | 1992-05-25 |
ES8608863A1 (es) | 1986-07-16 |
FI852235A0 (fi) | 1985-06-04 |
ATE73323T1 (de) | 1992-03-15 |
FI87990B (fi) | 1992-12-15 |
DK247285D0 (da) | 1985-06-03 |
JPS611614A (ja) | 1986-01-07 |
PT80583B (pt) | 1987-09-18 |
DK247285A (da) | 1985-12-05 |
DK164259C (da) | 1992-10-19 |
NO166063B (no) | 1991-02-18 |
FI852235L (fi) | 1985-12-05 |
AU4323685A (en) | 1985-12-12 |
NZ212268A (en) | 1988-10-28 |
KR860000068A (ko) | 1986-01-25 |
PT80583A (en) | 1985-07-01 |
EP0164959A2 (en) | 1985-12-18 |
CA1258232A (en) | 1989-08-08 |
DE3585560D1 (de) | 1992-04-16 |
GR851356B (xx) | 1985-11-25 |
EP0164959B1 (en) | 1992-03-11 |
ES543826A0 (es) | 1986-07-16 |
FI87990C (fi) | 1993-03-25 |
NO852225L (no) | 1985-12-05 |
US4806361A (en) | 1989-02-21 |
DK164259B (da) | 1992-06-01 |
MX159928A (es) | 1989-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL75403A (en) | Sustained release pharmaceutical compositions containing a pyridinone derivative for oral administration | |
IE812232L (en) | Composition | |
CA2282082A1 (fr) | Microgranules contenant du cisplatine | |
ZA827745B (en) | Derivatives of 3-amino pregn-5-ene,their salts,their preparation,their application as medicaments and compositions containing them | |
PT76573A (fr) | Procede de preparation de derives d'imidazo <1,2-a> pyridine et de compositions pharmaceutiques les contenant | |
IE851155L (en) | Benzo-(pyrano and thiopyrano)-pyridines | |
IL87122A0 (en) | Substituted thienoinidazole derivatives,process for the preparation thereof,pharmaceutical compositions containing them,and the use thereof as inhibitors of gastric acid secretion,as gastroprotectives and as medicaments for intestinal inflammations | |
EP0271151A3 (en) | Azumolene dosage form | |
IL69392A (en) | N-oxide nicotinamide derivatives,their preparation and pharmaceutical compositions containing them | |
IE56229B1 (en) | 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them | |
IL64439A0 (en) | 1,2-dihydro-5-(pyridinyl)nicotinamide derivatives,their preparation and pharmaceutical compositions containing them | |
CA2062976A1 (en) | Use of sebacic acid and derivatives thereof in enteral and parenteral nutrition and pharmaceutical compositions containing said compounds | |
JPS54126722A (en) | Slow release antibiotic tablet | |
IL64674A0 (en) | 5-(pyridinyl)-benzimidazole derivatives,their preparation and pharmaceutical compositions containing them | |
IL65162A0 (en) | Thioalkylamide of nicotinic acid 1-oxide and its salts,their preparation and pharmaceutical compositions containing them | |
AU2827684A (en) | Novel cephalosporin derivatives,pharmaceutical compositions containing the same,their use in therapy as antibiotics and aprocess for the preparation of the novel compounds | |
JPS57109722A (en) | Antitumor agent containing deoxyfluorouridine benzyloxylated at 4-position | |
IL85508A (en) | 2-substituted-4-(2-benzyl-aminophenyl)-1,4,5,7-tetra-hydro-5-oxofuro(3,4,-b)-pyridine-3-carboxylic acid derivatives and pharmaceutical compositions containing them |